BRIEF-Catalyst Pharma drops in premarket after cocaine de-addiction drug trial results

NEW YORK Thu Nov 8, 2012 8:39am EST

NEW YORK Nov 8 (Reuters) - Catalyst Pharmaceutical Partners Inc : * Catalyst Pharma drops 66.2 percent to 49 cents in premarket after cocaine de-addiction drug trial results

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.